ArticleJournal of the American Chemical Society2024

Backbone Modification Provides a Long-Acting Inverse Agonist of Pathogenic, Constitutively Active PTH1R Variants.

Shi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.